Support the Abortion is Health Care Everywhere Act

PAI announces acceptance into the WHO Civil Society Commission. Read more about the Commission: Read More
This update outlines what you need to know about the court case attacking access to mifepristone, one of two drugs most commonly used in medication abortion in the United States, as of October 2023. It describes what has happened and what is at stake if the FDA approval for mifepristone is rescinded. This update also outlines potential implications globally and provides clear and actionable next steps to learn more about this case and monitor similar threats to abortion access in other country contexts.
Stay informed about the issues impacting sexual and reproductive health and rights.